Your browser does not support iframes.
Florida Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock
(NQ:
CYCCP
)
7.500
USD
UNCHANGED
Last Price
/ Updated:
8:10 PM EDT, Jun 7, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
7.200 (1000)
Ask (Size)
8.500 (1000)
Prev. Close
7.500
Today's Range
7.500 - 7.500
52wk Range
2.061 - 10.45
Shares Outstanding
420,862
Dividend Yield
8.00%
Top News
More News
Cyclacel Pharmaceuticals Announces Closing of Underwritten Offering
May 21, 2013
from
GlobeNewswire News Releases
Cyclacel (CYCC) Prices 6.67M Common Stock Offering
May 16, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8346214 for the full story.
Read More
from
StreetInsider.com News Articles
More News
Read More
Cyclacel Pharmaceuticals Announces $20 Million Underwritten Offering
May 16, 2013
from
GlobeNewswire News Releases
Cyclacel Pharmaceuticals (CYCC) Announces Stock Offering
May 15, 2013
from
StreetInsider.com News Articles
Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 15, 2013
category
CYCCP
,
Benzinga
,
CYCC
, and 2 more.
from
Latest Articles from Benzinga.com
Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 15, 2013
from
GlobeNewswire News Releases
Cyclacel Reports First Quarter 2013 Financial Results
May 13, 2013
from
GlobeNewswire News Releases
Cyclacel Pharmaceuticals to Announce Release of First Quarter 2013 Financial Results
May 10, 2013
from
GlobeNewswire News Releases
Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock Shares Cross 8% Yield Mark
May 06, 2013
category
Stocks
from
Market News Video
Cyclacel Reports Updated Phase 2 Survival Data of Sapacitabine for MDS
April 30, 2013
from
GlobeNewswire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.